SaaS Metrics
Diagnostic Imaging Innovation
Angiography
AI Synthesis & Market Narrative
The FDA approval of IOMERVU, a new radiographic contrast agent for arteriograms and CT imaging, signifies continued innovation in diagnostic pharmaceuticals. This development addresses the demand for enhanced visualization in medical diagnostics.
Correlated Linguistic Patterns
["IOMERVU is a radiographic contrast agent"
"visualize blood vessels"
"computed tomography (CT) imaging"]
Driving Media Context
Trump says he is reviewing a new Iranian proposal to end the war but ‘can’t imagine that it would be acceptable’
Two semiofficial Iranian news outlets, Tasnim and Fars said Iran has sent a 14-point proposal via Pakistan in response to a nine-point U.S. proposal.
Calls grow over hospital care for jailed Iranian Nobel laureate Narges Mohammadi
On Friday her family said the 54-year-old had been taken from prison to a local hospital after a sharp deterioration in her health.
US warns shipping firms over paying Iran to transit Strait of Hormuz
BEIRUT, May 2: The United States is warning shipping companies they could face sanctions for making payments to Iran to safely pass through the Strait of Hor...
Drug Trials Snapshots: IOMERVU
IOMERVU is a radiographic contrast agent that is used during an arteriogram to visualize blood vessels in adult and pediatric patients. IOMERVU is also used ...
Perovskite solar cells are the 'impure' bad boys of next-gen photovoltaics
“Purity” is one of the many myths of perfection, suggesting that absolute conformity is the only way to produce supreme value. Just as that claim is false fo...
The Best GLP-1 Drug on the Market Is Even Better Than We Knew
A pair of new studies suggest tirzepatide can keep heart disease at bay in high-risk groups.
Inventor recalls eye imaging breakthrough
If you’ve been to an eye doctor and had an image taken of the inside of your eye, chances are good it was done with optical coherence tomography (OCT)—a tech...
Retinal arteriovenous crossings as spatiotemporal stress fields: a quantitative Doppler OCT flowmetry study
This study aimed to investigate the development of branch retinal vein occlusion (BRVO) from a hemodynamic stress perspective, rather than focusing solely on...
Machine learning–based risk stratification identifies heart failure with preserved ejection fraction as an independent predictor of adverse outcomes in hypertrophic cardiomyopathy
Scientific Reports - Machine learning–based risk stratification identifies heart failure with preserved ejection fraction as an independent predictor of adve...
‘How can you check if you have a heart blockage. My blood pressure is always good, but aren’t there blood tests that can give us clues?’
Waiting for a major symptom can be risky. If you have risk factors or unexplained symptoms, don't ignore them